HIGHMARK, INC. for HIGHMARK INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Insulin, Drug Pricing, Drug Patent Reform, Pharmacy Benefit Manager (PBM) Reform H.R. 1488/S. 954 - The Affordable Insulin Now Act A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals. S. 127. - The Pharmacy Benefit Manager Transparency Act A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. S. 142 -- The Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Health Issues HCR
Affordability of Coverage, Telehealth, COVID/End of Public Health Emergency, Mental Health, Workforce Shortages, Site-Neutral Payments, Social Determinants of Health, Medical Loss Ratio H.R. 1843/S. 1001 - The Telehealth Expansion Act A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Medicare/Medicaid MMM
Medicare Advantage Rate Notice, Risk Adjustment, Star Ratings, Medicare Advantage RADV Rule, Prior Authorization in Medicare Advantage, Medicaid Redeterminations, Site Neutral Payments, Social Determinants of Health S. 1002 -- No UPCODE Act A bill to amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Taxation/Internal Revenue Code TAX
Amortization of Research and Experimental Expenditures S. 866 - The American Innovation and Jobs Act A bill to amend the Internal Revenue Code of 1986 to enhance tax benefits for research activities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.